boy
idiopath
seizur
disord
sinc
age
year
put
phenobarbiton
mgkg
per
day
week
prior
first
admiss
previou
histori
mild
skin
rash
carbamazepin
signific
past
medic
famili
histori
develop
symptom
day
prior
admiss
given
antibiot
gener
practition
admiss
fever
itchi
gener
urticari
skin
rash
treat
case
allerg
reaction
given
cours
prednisolon
mgkg
per
day
rash
fever
respond
rapidli
routin
blood
test
includ
liver
function
normal
seizur
becam
frequent
phenobarbiton
recommenc
prior
discharg
return
day
later
worsen
skin
rash
fever
occas
phenobarbiton
consid
like
caus
reaction
examin
reveal
gener
lymphadenopathi
widespread
itchi
erythemat
maculopapular
rash
baselin
blood
investig
show
haemoglobin
level
gdl
total
white
cell
count
eosinophil
lymphocyt
platelet
count
liver
function
normal
chest
radiograph
reveal
pneumon
chang
remain
febril
repeat
liver
function
day
show
evid
hepat
rais
alanin
aminotransferas
alt
iul
intern
normal
ratio
inr
clinic
pictur
compat
hypersensit
syndrom
ah
prednisolon
mgkg
per
day
restart
day
associ
improv
allow
discharg
day
admiss
alt
time
discharg
iul
inr
normal
admiss
stay
isol
ward
differ
cubicl
two
patient
sever
acut
respiratori
syndrom
sar
day
later
high
swing
fever
malais
myalgia
dri
cough
worsen
skin
rash
examin
chest
clear
liver
enlarg
cm
right
costal
margin
chest
radiograph
show
bilater
basal
hazi
possibl
diagnosi
sar
suspect
manag
accord
local
guidelin
time
includ
ribavirin
alt
admiss
iul
inr
blood
glucos
ammonia
level
normal
next
day
temperatur
start
subsid
progress
pneumon
chang
serial
chest
radiograph
preliminari
viral
screen
nasopharyng
aspir
sampl
use
rapid
test
polymeras
chain
reaction
neg
coronaviru
ribavirin
stop
fever
pattern
fig
becam
unsettl
condit
deterior
day
later
becam
tire
jaundic
less
respons
urgent
cranial
comput
tomographi
ct
ultrasound
scan
abdomen
unremark
inr
subsequ
went
highest
ammonia
level
alt
drop
iul
consid
dramat
deterior
could
relat
ah
dose
intraven
immun
globulin
ivig
gkg
given
prior
transfer
region
liver
unit
possibl
liver
transplant
possibl
caus
liver
failur
unrev
level
conscious
deterior
intub
ventil
howev
next
h
prepar
liver
transplant
condit
improv
inr
drop
ammonia
level
trend
downward
extub
h
develop
thrombocytopaenia
requir
platelet
transfus
view
possibl
relat
ongo
ah
dose
ivig
gkg
given
signific
improv
platelet
count
five
day
second
dose
ivig
develop
high
fever
increas
rash
extrem
third
dose
ivig
gkg
prednisolon
mgkgday
given
associ
dramat
drop
temperatur
improv
rash
gener
condit
within
h
hypersensit
syndrom
ah
may
underrecogn
potenti
fatal
cours
recoveri
fluctuat
long
even
mild
case
describ
child
sever
ah
whose
present
complic
symptom
sign
compat
diagnosi
sar
subsequ
respons
ivig
steroid
may
suggest
underli
autoimmun
type
pathogenesi
ah
idiosyncrat
advers
reaction
report
occur
anticonvuls
contain
aromat
ring
carbamazepin
phenobarbit
phenytoin
patient
previou
mild
reaction
carbamazepin
could
well
earli
warn
sign
prone
ah
condit
first
describ
use
phenytoin
true
incid
unknown
estim
exposur
review
bessmertni
et
al
case
ah
identifi
period
year
eight
patient
take
phenytoin
six
carbamazepin
four
phenobarbit
alon
combin
mean
age
year
mean
time
exposur
develop
symptom
day
occurr
ah
relationship
underli
neurolog
condit
treatment
start
addit
rash
fever
present
patient
definit
common
featur
ah
lymphocytosi
elev
erythrocyt
sediment
rate
elev
aminotransferas
lymphadenopathi
eosinophilia
coagulopathi
leucocytosi
leucopaenia
hyperbilirubinaemia
nephriti
bessmertni
seri
children
recov
except
one
die
liver
failur
child
take
combin
phenytoin
carbamazepin
delay
week
start
symptom
medic
stop
underli
pathogenesi
ah
unknown
evid
condit
immun
mediat
autoimmun
hypothyroid
recogn
late
complic
follow
ah
other
propos
ah
form
diseas
use
steroid
condit
controversi
posit
neg
result
report
literatur
bessmertni
seri
clinic
outcom
similar
children
receiv
system
steroid
therapi
earlier
report
use
ivig
ah
improv
term
rise
platelet
count
allevi
symptom
fever
rash
oedema
oral
ulcer
seen
within
h
therapi
patient
fluctuat
cours
ah
necessit
use
multipl
dose
ivig
steroid
occas
definit
clinic
laboratori
respons
suggest
ivig
block
cell
surfac
receptor
keratinocyt
play
role
trigger
apoptosi
antibodi
present
ivig
also
shown
block
keratinocyt
death
vitro
patient
toxic
epiderm
necrolysi
similar
mechan
could
respons
improv
seen
ah
patient
multipl
exacerb
cours
ill
first
episod
could
explain
reintroduct
phenobarbiton
second
episod
could
induc
intercurr
infect
diagnosi
sar
suspect
patient
high
fever
cough
chest
radiograph
chang
malais
myalgia
stay
isol
ward
sar
case
treat
although
direct
contact
like
strict
infect
control
measur
practic
medic
nurs
staff
consid
feasibl
transmiss
could
occur
earli
adult
experi
suggest
patient
underli
hepat
problem
may
higher
risk
morbid
mortal
affect
sar
neg
stop
ribavirin
h
ribavirin
possibl
exacerb
factor
hepat
damag
consid
unlik
liver
dysfunct
associ
use
never
report
drug
recogn
treatment
chronic
hepat
c
summari
import
clinician
awar
hypersensit
reaction
variou
aromat
common
prompt
withdraw
culprit
medic
usual
result
complet
resolut
symptom
case
howev
patient
continu
exacerb
week
stop
treatment
role
steroid
ivig
condit
still
unresolv
case
use
temporarili
associ
clinic
laboratori
improv
whether
secondari
viral
bacteri
infect
cours
reaction
may
exacerb
condit
unknown
